Status:
COMPLETED
The Aging Brain ANSWERS Program
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Richard L. Roudebush VA Medical Center
Cleveland State University
Conditions:
Traumatic Brain Injury
Alzheimer Disease
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study will test the effectiveness of an intervention for Veterans diagnosed with Alzheimer's Disease (AD) or Traumatic Brain Injury (TBI) and the burden on their informal (family/friend) caregive...
Detailed Description
The majority of people with Alzheimer's (AD) and Traumatic brain Injury (TBI) are cared for in primary care settings and receive significant amounts of care and assistance in activities of daily livin...
Eligibility Criteria
Inclusion
- Veterans: 1)Diagnosis of AD or TBI 2) Receives Primary Care from Veterans Administration Medical Center (VAMC)
- Caregivers: 1) Primary caregiver (family or friend) of a Veteran with AD or TBI 2) Plans to provide care for 1 year or longer
- Both: 1) Over 18 years of age 2) Speak and understand English 3) access to telephone
Exclusion
- Veterans: 1) Resides in nursing home or long term care facility 2) currently receiving care in GRACE clinic 3) Enrolled in ANSWERS-VA research study
- Caregivers: 1) Does not consider him/herself a caregiver for Veteran 2) Serious medical illness limiting ability to participate
- Both: Unable to contact within 10 calls Age \< 18 years Either caregiver or Veteran denies that they have AD or a TBI Either the caregiver or Veteran does not want to participate Not fluent in the English language Difficulty hearing or talking by telephone Has a terminal illness (e.g., cancer, end of life condition with decreased life expectancy, renal failure requiring dialysis) History of hospitalization for alcohol or drug abuse History of severe mental illness (e.g., suicidal tendencies, severe untreated depression or bipolar disorder, or schizophrenia) Prisoner or on house arrest
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT03397667
Start Date
August 1 2018
End Date
May 31 2023
Last Update
December 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Richard L. Roudebush VAMC
Indianapolis, Indiana, United States, 46202